A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias

Neurology

Volumn 77, Issue 22, 2011, Pages 1996-1997

  Hess, Ellen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; PLACEBO;

ATAXIA; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INHIBITION; EPISODIC ATAXIA; FAMILIAL EPISODIC ATAXIA; HEREDITARY ATAXIA; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 82955228794     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31823c162b     Document Type: Editorial

References (4)

1. M Strupp R Kalla J Claassen A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias Neurology 77 2011 269 275
2. M Strupp R Kalla M Dichgans T Freilinger S Glasauer T Brandt Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine Neurology 62 2004 1623 1625
3. CJ Weisz RS Raike LE Soria-Jasso EJ Hess Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering J Neurosci 25 2005 4141 4145
4. D Stefoski FA Davis WE Fitzsimmons 4-Aminopyridine in multiple sclerosis: prolonged administration Neurology 41 1991 1344 1348